相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status
Piera Capranzano et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2013)
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Patrick T. O'Gara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Effects of cangrelor in coronary artery disease patients with and without diabetes mellitus: an in vitro pharmacodynamic investigation
Jose L. Ferreiro et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2013)
A Randomized, Double-Blind, Active-Controlled Phase 2 Trial to Evaluate a Novel Selective and Reversible Intravenous and Oral P2Y12 Inhibitor Elinogrel Versus Clopidogrel in Patients Undergoing Nonurgent Percutaneous Coronary Intervention The INNOVATE-PCI Trial
Robert C. Welsh et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
Pharmacokinetic and Pharmacodynamic Effects of Elinogrel Results of the Platelet Function Substudy From the Intravenous and Oral Administration of Elinogrel to Evaluate Tolerability and Efficacy in Nonurgent Percutaneous Coronary Intervention Patients (INNOVATE-PCI) Trial
Dominick J. Angiolillo et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease
Jose Luis Ferreiro et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Cigarette Smoking Is Associated With a Dose-Response Effect in Clopidogrel-Treated Patients With Diabetes Mellitus and Coronary Artery Disease Results of a Pharmacodynamic Study
Masafumi Ueno et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2012)
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease Position Paper
Raffaele De Caterina et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes
B. Rocca et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Pierluigi Tricoci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Vorapaxar in the Secondary Prevention of Atherothrombotic Events
David A. Morrow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
Jean-Philippe Collet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Diagnosis of Diabetes
Silvio E. Inzucchi
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus
Siva Suryadevara et al.
THROMBOSIS AND HAEMOSTASIS (2012)
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Jeffrey L. Anderson et al.
CIRCULATION (2011)
Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome
Jose Luis Ferreiro et al.
CIRCULATION (2011)
Pharmacodynamic Effects of Different Aspirin Dosing Regimens in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease
Davide Capodanno et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2011)
A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial
Dominick J. Angiolillo et al.
EUROPEAN HEART JOURNAL (2011)
Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study (Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo)
David Vivas et al.
HEART (2011)
Optimizing Platelet Inhibition in Clopidogrel Poor Metabolizers Therapeutic Options and Practical Considerations
Dominick J. Angiolillo et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2011)
Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention The GRAVITAS Randomized Trial
Matthew J. Price et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Impact of Insulin Receptor Substrate-1 Genotypes on Platelet Reactivity and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin
P. Fontana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Impacto del tratamiento adyuvante con cilostazol comparado con dosis altas de mantenimiento de clopidogrel en pacientes con diabetes mellitus y respuesta subóptima
José L. Ferreiro et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2011)
Functional profile of the platelet P2Y12 receptor signalling pathway in patients with type 2 diabetes mellitus and coronary artery disease
Masafumi Ueno et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy
Dominick J. Angiolillo et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Diabetes and the platelet: Toward new therapeutic paradigms for diabetic atherothrombosis
Olivier Morel et al.
ATHEROSCLEROSIS (2010)
Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease
Hertzel C. Gerstein et al.
CIRCULATION (2010)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2010)
Platelet thrombin receptor antagonism and atherothrombosis
Dominick J. Angiolillo et al.
EUROPEAN HEART JOURNAL (2010)
Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
Stefan James et al.
EUROPEAN HEART JOURNAL (2010)
Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes A Position Statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation
Michael Pignone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Impact of Chronic Kidney Disease on Platelet Function Profiles in Diabetes Mellitus Patients With Coronary Artery Disease Taking Dual Antiplatelet Therapy
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
Willibald Hochholzer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Hyperglycemia: a prothrombotic factor?
B. A. Lemkes et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial
Shamir R. Mehta et al.
LANCET (2010)
Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes
NEW ENGLAND JOURNAL OF MEDICINE (2010)
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin
Isabella Russo et al.
OBESITY (2010)
Platelet Adenosine Diphosphate P2Y(12) Receptor Antagonism: Benefits and Limitations of Current Treatment Strategies and Future Directions
Dominick J. Angiolillo et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2010)
A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease
Erik Lerkevang Grove et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus
S. B. Mortensen et al.
THROMBOSIS RESEARCH (2010)
Elinogrel: pharmacological principles, preclinical and early phase clinical testing
Masafumi Ueno et al.
FUTURE CARDIOLOGY (2010)
Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y(12) receptor antagonist
Davide Capodanno et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Diabetes, vascular complications and antiplatelet therapy: open problems
A. M. Cerbone et al.
ACTA DIABETOLOGICA (2009)
Safety and feasibility of adjunctive antiplatelet therapy with intravenous elinogrel, a direct-acting and reversible P2Y12 ADP-receptor antagonist, before primary percutaneous intervention in patients with ST-elevation myocardial infarction: The Early Rapid ReversAl of Platelet ThromboSis with Intravenous Elinogrel before PCI to Optimize REperfusion in Acute Myocardial Infarction (ERASE MI) pilot trial
Jeffrey S. Berger et al.
AMERICAN HEART JOURNAL (2009)
Variability in Responsiveness to Oral Antiplatelet Therapy
Dominick J. Angiolillo
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux
Anna C. Calkin et al.
CIRCULATION (2009)
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study
Paul A. Gurbel et al.
CIRCULATION (2009)
Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions
Dominick J. Angiolillo
DIABETES CARE (2009)
Insulin, Insulin Resistance, and Platelet Signaling in Diabetes
Voahanginirina Randriamboavonjy et al.
DIABETES CARE (2009)
Factors Contributing to Increased Platelet Reactivity in People With Diabetes
David J. Schneider
DIABETES CARE (2009)
Randomized Comparison of Adjunctive Cilostazol Versus High Maintenance Dose Clopidogrel in Patients With High Post-Treatment Platelet Reactivity
Young-Hoon Jeong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Insulin/IGF-1 hybrid receptor expression on human platelets: consequences for the effect of insulin on platelet function
R. W. Hunter et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial
Gilles Montalescot et al.
LANCET (2009)
Intravenous Platelet Blockade with Cangrelor during PCI.
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Platelet Inhibition with Cangrelor in Patients Undergoing PCI.
Robert A. Harrington et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Intensive versus Conventional Glucose Control in Critically Ill Patients
S. Finfer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Platelet dysfunction in central obesity
G. Anfossi et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2009)
Pharmacology of emerging novel platelet inhibitors
Dominick J. Angiolillo et al.
AMERICAN HEART JOURNAL (2008)
Oxidative stress and platelets
Jane E. Freedman
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38
Stephen D. Wiviott et al.
CIRCULATION (2008)
Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone
Voahanginirina Randriamboavonjy et al.
CIRCULATION (2008)
Endothelial dysfunction, impaired endogenous platelet inhibition and platelet activation in diabetes and atherosclerosis
Andreas Schaefer et al.
CURRENT VASCULAR PHARMACOLOGY (2008)
A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study
Dominick J. Angiolillo et al.
EUROPEAN HEART JOURNAL (2008)
Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes A Randomized Controlled Trial
Hisao Ogawa et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes -: The PERISCOPE randomized controlled trial
Steven E. Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease
Sasidhar Guthikonda et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Patients With Poor Responsiveness to Thienopyridine Treatment or With Diabetes Have Lower Levels of Circulating Active Metabolite, but Their Platelets Respond Normally to Active Metabolite Added Ex Vivo
David Erlinge et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes
Frederick Feit et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Drug-eluting stenting followed by cilostazol treatment reduces late Restenosis in patients with diabetes mellitus - The DECLARE-DIABETES trial (a randomized comparison of triple antiplatelet therapy with dual antiplatelet therapy after drug-eluting stent implantation in diabetic patients)
Seung-Whan Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Aspirin resistance and risk of cardiovascular morbidity: systematic review and meta-analysis
George Krasopoulos et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Mechanisms of disease:: Platelet activation and atherothrombosis
Giovanni Davi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients - An analysis from the aspirin-induced platelet effect (ASPECT) study
Joseph DiChiara et al.
DIABETES (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Inhibition of platelet aggregation by AZD6140, A reversible oral P2Y12 receptor antagonist, compared with clopidogral in patients with acute coronary syndrome
Robert F. Storey et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events - A systematic review and meta-analysis
Jaapjan D. Snoep et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of Clopidogrel before percutaneous coronary intervention
Dirk Sibbing et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Rinnonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply
Lars Ryden et al.
EUROPEAN HEART JOURNAL (2007)
Variability in individual responsiveness to clopidogrel - Clinical implications, management, and future perspectives
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin
S. Guthikonda et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease - Results of the Optimizing antiPlatelet Therapy In diabetes MellitUS (OPTIMUS) study
Dominick J. Angiolillo et al.
CIRCULATION (2007)
Alterations of adenine nucleotide metabolism and function of blood platelets in patients with diabetes
Anna Michno et al.
DIABETES (2007)
Platelet response to clopidogrel is attenuated in diabetic patients undergoing coronary stent implantation
Tobias Geisler et al.
DIABETES CARE (2007)
Platelet aggregation in obese and diabetic subjects: Association with leptin level
Chiyo Sugiyama et al.
PLATELETS (2007)
Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non-insulin-dependent diabetes mellitus
Isaac Jardin et al.
PLATELETS (2006)
Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers
Dermot Cox et al.
STROKE (2006)
Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment
Dominick J. Angiolillo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Safety of coronary Sirolimus-Eluting Stents in daily clinical practice - One-year follow-up of the e-cypher registry
P Urban et al.
CIRCULATION (2006)
Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents
PK Kuchulakanti et al.
CIRCULATION (2006)
Effects of VLDL and remnant particles on platelets
Rasaq Olufadi et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2006)
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
ZM Chen et al.
LANCET (2005)
Cyclooxygenase-1 haplotype modulates platelet response to aspirin
AO Maree et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Atherothrombosis and high-risk plaque Part I: Evolving concepts
V Fuster et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics -: The PCI-CLARITY study
MS Sabatine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggregation in platelets from type 2 diabetic patients
PC Redondo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment
DJ Angiolillo et al.
DIABETES (2005)
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
I Iakovou et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
FASTTRACK Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2):: effects on mortality and morbidity
K Malmberg et al.
EUROPEAN HEART JOURNAL (2005)
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
MS Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
P2Y12 receptors play a significant role in the development of platelet microaggregation in patients with diabetes
H Matsuno et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Advanced glycation endproducts - role in pathology of diabetic complications
N Ahmed
DIABETES RESEARCH AND CLINICAL PRACTICE (2005)
Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood
H Kariyazono et al.
BLOOD COAGULATION & FIBRINOLYSIS (2004)
Improved metabolic control decreases platelet activation markers in patients with type-2 diabetes
N Eibl et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes
DK McGuire et al.
AMERICAN HEART JOURNAL (2004)
Platelet activation in type 2 diabetes mellitus
P Ferroni et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease
JS Sidhu et al.
AMERICAN HEART JOURNAL (2004)
Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study
GGN Serneri et al.
EUROPEAN HEART JOURNAL (2004)
Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus
FK Keating et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I
MA Creager et al.
CIRCULATION (2003)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
SR Steinhubl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease
RF Storey et al.
PLATELETS (2002)
Amplified benefit of Clopidogrel versus aspirin in patients with diabetes mellitus
DL Bhatt et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus
Y Hasegawa et al.
THROMBOSIS RESEARCH (2002)
Glycated low density lipoproteins modify platelet properties: A compositional and functional study
G Ferretti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Inhibition of platelet-collagen interaction - An in vivo action of insulin abolished by insulin resistance in obesity
J Westerbacka et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
F Catella-Lawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with Non-ST-segment-elevation acute coronary syndromes
M Roffi et al.
CIRCULATION (2001)
Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow
NA Turner et al.
BLOOD (2001)
Effects of P2Y1 and P2Y12 receptor antagonists on platelet aggregation induced by different agonists in human whole blood
RF Storey et al.
PLATELETS (2001)
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
SR Mehta et al.
LANCET (2001)
Platelet dysfunction in type 2 diabetes
AI Vinik et al.
DIABETES CARE (2001)
Platelet antioxidant enzymes in insulin-dependent diabetes mellitus
G Seghieri et al.
CLINICA CHIMICA ACTA (2001)
Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro
R Assert et al.
DIABETOLOGIA (2001)
Impact of diabetes on long-term prognosis in patients with unstable angina and non-Q-wave myocardial infarction - Results of the OASIS (Organization to Assess Strategies for Ischemic Syndromes) registry
K Malmberg et al.
CIRCULATION (2000)
Platelet function in patients with familial hypertriglyceridemia:: Evidence that platelet reactivity is modulated by apolipoprotein E content of very-low-density lipoprotein particles
J Pedreño et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)
分享论文
